The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Shanghai Henlius Biotech
First-line serplulimab plus HLX04 and XELOX versus placebo plus bevacizumab and XELOX in metastatic colorectal cancer: A phase 2/3 study.
 
Rui-Hua Xu
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; HenRui; Junshi Biosciences; KYM Biosciences; Merck Serono; Roche
 
Feng Wang
No Relationships to Disclose
 
Junjie Peng
No Relationships to Disclose
 
Xinjun Liang
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Yanhong Deng
No Relationships to Disclose
 
Kehe Chen
No Relationships to Disclose
 
Mingjun Zhang
No Relationships to Disclose
 
Jingdong Zhang
No Relationships to Disclose
 
Wei Wang
No Relationships to Disclose
 
Bangwei Cao
No Relationships to Disclose
 
Yongdong Jin
No Relationships to Disclose
 
Meili Sun
No Relationships to Disclose
 
Yuan Lin
No Relationships to Disclose
 
Su-Xia Luo
Consulting or Advisory Role - KYM Biosciences
 
Zhen Li
No Relationships to Disclose
 
Liu Yang
No Relationships to Disclose
 
Qingyu Wang
No Relationships to Disclose
 
Jing Li
Employment - Shanghai Henlius Biotech
 
Jun Zhu
Employment - Shanghai Henlius Biotech